1. Rockwood K. Frailty and its definition: a worthy challenge. J Am Geriatr Soc. 2005;53:1069–70.
2. Brown M, Sinacore DR, Binder EF, Kohrt WM. Physical and per- formance measures for the identification of mild to moderate frailty. J Gerontol A Biol Sci Med Sci. 2000;55:M350–M5.
3. Verghese J, Holtzer R, Lipton RB, Wang C. Mobility stress test approach to predicting frailty, disability, and mortality in high‐func- tioning older adults. J Am Geriatr Soc. 2012;60:1901–5.
4. Clegg A, Rogers L, Young J. Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review. Age Ageing. 2015;44:148–52.
5. Lee JS-J, He K, Harbaugh CM, et al. Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J Vasc Surg. 2011;53:912–7.
6. Paknikar R, Friedman J, Cron D, et al. Psoas muscle size as a frailty measure for open and transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2016;151:745–51.
7. Hawkins RB, Mehaffey JH, Charles EJ, et al. Psoas muscle size predicts risk-adjusted outcomes after surgical aortic valve replace- ment. Ann Thorac Surg. 2018;106:39–45.
8. Englesbe MJ, Lee JS, He K, et al. Analytic morphomics, core mus- cle size, and surgical outcomes. Ann Surg. 2012;256:255–61.
9. Mamane S, Mullie L, Piazza N, et al. Psoas muscle area and all- cause mortality after Transcatheter aortic valve replacement: the Montreal-Munich Study. Can J Cardiol. 2016;32:177–82.
10. Heberton GA, Nassif M, Bierhals A, et al. Usefulness of psoas muscle area determined by computed tomography to predict mor- tality or prolonged length of hospital stay in patients undergoing left ventricular assist device implantation. Am J Cardiol. 2016;118: 1363–7.
11. Ikeno Y, Koide Y, Abe N, et al. Impact of sarcopenia on the out- comes of elective total arch replacement in the elderly. Eur J Cardiothorac Surg. 2017;51:1135–41.
12. Kofler M, Reinstadler SJ, Mayr A, et al. Prognostic implications of psoas muscle area in patients undergoing transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2019;55:210–216.
13. Okamura H, Kimura N, Tanno K, et al. The impact of preoperative sarcopenia, defined based on psoas muscle area, on long-term outcomes of heart valve surgery. J Thorac Cardiovasc Surg. 2019;157:1071–1079.e3.
14. Beach JM, Mihaljevic T, Svensson LG, et al. Coronary artery dis- ease and outcomes of aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2013;61:837–48.
15. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.
16. Amini N, Spolverato G, Gupta R, et al. Impact total psoas volume on short- and long-term outcomes in patients undergoing curative resection for pancreatic adenocarcinoma: a new tool to assess sarcopenia. J Gastrointest Surg. 2015;19:1593–602.
17. Valero V 3rd, Amini N, Spolverato G, et al. Sarcopenia adversely impacts postoperative complications following resection or trans- plantation in patients with primary liver tumors. J Gastrointest Surg. 2015;19:272–81.
18. Delmonico MJ, Harris TB, Lee J-S, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impair- ment with aging in older men and women. J Am Geriatr Soc. 2007;55:769–74.
19. Moss S, Doyle M, Nagaraja V, Peeceeyen S. A systematic review and meta-analysis of the clinical outcomes of TAVI versus SAVR in the octogenarian population. Indian J Thorac Cardiovasc Surg. 2020;36:356–64.
20. Kitamura A, Seino S, Abe T, et al. Sarcopenia: prevalence, associ- ated factors, and the risk of mortality and disability in Japanese older adults. J Cachexia Sarcopenia Muscle. 2021;12:30–8.